adderall
Generic: dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Labeler: teva pharmaceuticals usa, inc.Drug Facts
Product Profile
Brand Name
adderall
Generic Name
dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Labeler
teva pharmaceuticals usa, inc.
Dosage Form
TABLET
Routes
Active Ingredients
amphetamine aspartate monohydrate 3.125 mg/1, amphetamine sulfate 3.125 mg/1, dextroamphetamine saccharate 3.125 mg/1, dextroamphetamine sulfate 3.125 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
57844-112
Product ID
57844-112_79af1dc6-c7cf-41b1-a750-e9b47c2187ff
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA040422
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2014-06-18
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
57844112
Hyphenated Format
57844-112
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
adderall (source: ndc)
Generic Name
dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate (source: ndc)
Application Number
ANDA040422 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 3.125 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (57844-112-01)
Packages (1)
Ingredients (4)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "79af1dc6-c7cf-41b1-a750-e9b47c2187ff", "openfda": {"unii": ["O1ZPV620O4", "6DPV8NK46S", "G83415V073", "JJ768O327N"], "rxcui": ["541363", "541365", "541878", "541879", "541892", "541894", "577957", "577960", "577961", "577962", "687043", "687045", "1009145", "1009147"], "spl_set_id": ["f22635fe-821d-4cde-aa12-419f8b53db81"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (57844-112-01)", "package_ndc": "57844-112-01", "marketing_start_date": "20140618"}], "brand_name": "Adderall", "product_id": "57844-112_79af1dc6-c7cf-41b1-a750-e9b47c2187ff", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]"], "product_ndc": "57844-112", "dea_schedule": "CII", "generic_name": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Adderall", "active_ingredients": [{"name": "AMPHETAMINE ASPARTATE MONOHYDRATE", "strength": "3.125 mg/1"}, {"name": "AMPHETAMINE SULFATE", "strength": "3.125 mg/1"}, {"name": "DEXTROAMPHETAMINE SACCHARATE", "strength": "3.125 mg/1"}, {"name": "DEXTROAMPHETAMINE SULFATE", "strength": "3.125 mg/1"}], "application_number": "ANDA040422", "marketing_category": "ANDA", "marketing_start_date": "20140618", "listing_expiration_date": "20261231"}